WallStreetZenWallStreetZen

NASDAQ: EXOZ
Exozymes Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Be the first to know when Wall Street analysts revise their EXOZ stock forecasts and price targets.

Forecast return on equity

Is EXOZ forecast to generate an efficient return?

Company
-121.77%
Industry
-10.18%
Market
155.03%
EXOZ's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is EXOZ forecast to generate an efficient return on assets?

Company
-55.74%
Industry
-4.1%
EXOZ is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

EXOZ earnings per share forecast

What is EXOZ's earnings per share in the next 3 years based on estimates from 3 analysts?

Avg 1 year Forecast
-$1.21
Avg 2 year Forecast
-$1.14
Avg 3 year Forecast
-$0.48

EXOZ vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
EXOZ$4.31N/AN/A
YARW$14.91$58.00+289.00%Strong Buy
ALDX$0.65$5.50+750.08%Buy
ELTX$1.56$14.33+818.78%Strong Buy
PTHS$10.15$52.00+412.32%Strong Buy
View Top Biotech Stocks

Exozymes Stock Forecast FAQ

What is EXOZ's earnings growth forecast for 2026-2028?

(NASDAQ: EXOZ) Exozymes's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 13.69%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 67.03%.

Exozymes's earnings in 2026 is -$10,190,888.On average, 3 Wall Street analysts forecast EXOZ's earnings for 2026 to be -$11,265,714, with the lowest EXOZ earnings forecast at -$10,823,921, and the highest EXOZ earnings forecast at -$11,597,058. On average, 3 Wall Street analysts forecast EXOZ's earnings for 2027 to be -$10,603,025, with the lowest EXOZ earnings forecast at -$10,187,220, and the highest EXOZ earnings forecast at -$10,914,878.

In 2028, EXOZ is forecast to generate -$4,449,484 in earnings, with the lowest earnings forecast at -$4,274,994 and the highest earnings forecast at -$4,580,351.

If you're new to stock investing, here's how to buy Exozymes stock.

What is EXOZ's forecast return on equity (ROE) for 2026-2028?

(NASDAQ: EXOZ) forecast ROE is -121.77%, which is considered weak.

What is EXOZ's Earnings Per Share (EPS) forecast for 2026-2028?

(NASDAQ: EXOZ) Exozymes's current Earnings Per Share (EPS) is -$1.19. On average, analysts forecast that EXOZ's EPS will be -$1.21 for 2026, with the lowest EPS forecast at -$1.17, and the highest EPS forecast at -$1.25. On average, analysts forecast that EXOZ's EPS will be -$1.14 for 2027, with the lowest EPS forecast at -$1.10, and the highest EPS forecast at -$1.18. In 2028, EXOZ's EPS is forecast to hit -$0.48 (min: -$0.46, max: -$0.49).

What is EXOZ's forecast return on assets (ROA) for 2026-2028?

(NASDAQ: EXOZ) forecast ROA is -55.74%, which is lower than the forecast US Biotechnology industry average of -4.1%.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.